Aemetis (NASDAQ:AMTX) Raised to Hold at Wall Street Zen

Aemetis (NASDAQ:AMTXGet Free Report) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report released on Sunday.

A number of other research firms have also recently commented on AMTX. Loop Capital set a $1.75 price target on shares of Aemetis in a research note on Thursday, March 12th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aemetis in a report on Wednesday, January 21st. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $8.25.

Check Out Our Latest Stock Report on AMTX

Aemetis Trading Up 3.8%

Shares of AMTX opened at $2.70 on Friday. The company has a market cap of $179.90 million, a PE ratio of -2.03 and a beta of 2.61. The stock has a 50-day moving average price of $1.67 and a 200-day moving average price of $1.90. Aemetis has a 12-month low of $1.22 and a 12-month high of $3.66.

Aemetis (NASDAQ:AMTXGet Free Report) last issued its quarterly earnings data on Thursday, March 12th. The specialty chemicals company reported ($0.24) EPS for the quarter, topping the consensus estimate of ($0.28) by $0.04. The business had revenue of $43.31 million for the quarter, compared to analysts’ expectations of $72.07 million. As a group, analysts predict that Aemetis will post -2.07 earnings per share for the current year.

Institutional Trading of Aemetis

A number of hedge funds have recently bought and sold shares of AMTX. Vanguard Group Inc. grew its position in Aemetis by 15.3% during the third quarter. Vanguard Group Inc. now owns 2,479,163 shares of the specialty chemicals company’s stock valued at $5,578,000 after acquiring an additional 329,760 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Aemetis by 5.0% in the 4th quarter. Geode Capital Management LLC now owns 693,453 shares of the specialty chemicals company’s stock worth $964,000 after acquiring an additional 33,286 shares during the last quarter. Marshall Wace LLP boosted its stake in shares of Aemetis by 289.3% in the 4th quarter. Marshall Wace LLP now owns 559,754 shares of the specialty chemicals company’s stock valued at $778,000 after purchasing an additional 415,978 shares in the last quarter. State Street Corp boosted its stake in shares of Aemetis by 13.9% in the 4th quarter. State Street Corp now owns 260,299 shares of the specialty chemicals company’s stock valued at $362,000 after purchasing an additional 31,700 shares in the last quarter. Finally, Jane Street Group LLC bought a new position in shares of Aemetis during the 2nd quarter valued at $634,000. Institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

(Get Free Report)

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.

Featured Stories

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.